doi:10.3969/j.issn.1671-2587.2022.02.026

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2022, Vol. 24 ›› Issue (2): 264-267.DOI: 10.3969/j.issn.1671-2587.2022.02.026

Previous Articles Next Articles

Received:2021-10-15 Published:2022-04-12

[1] JUARRANZ Y.Molecular and cellular basis of autoimmune diseases[J]. Cells,2021,10(2):474.
[2] SMILEK D E,ST CLAIR E W.Solving the puzzle of autoimmunity:critical questions[J].F1000Prime Rep,2015,7:17.
[3] RAYNER F,ISAACS J D.Therapeutic tolerance in autoimmune disease[J].Semin Arthritis Rheum,2018,48(3):558-562.
[4] RANGANATHAN D,JOHN G T.Therapeutic plasma exchange in renal disorders[J].Indian J Nephrol,2019,29(3):151-159.
[5] FERNÁNDEZ-ZARZOSO M,GÓMEZ-SEGUÍ I,DE LA RUBIA J.Therapeutic plasma exchange:review of current indications[J].Transfus Apher Sci,2019,58(3):247-253.
[6] PADMANABHAN A,CONNELLY-SMITH L,AQUI N,et al.Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis:the eighth special issue[J].J Clin Apher,2019,34(3):171-354.
[7] AL HAMZI H A,AL-MAYOUF S M,AL SHAIKH A A,et al. Early and late effects of therapeutic plasma exchange in patients with systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis:a single-center experience[J].Saudi J Kidney Dis Transpl,2019,30(4):775-780.
[8] LEWIS E J,HUNSICKER L G,LAN S P,et al.A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group[J]. N Engl J Med,1992,326(21):1373-1379.
[9] KRONBICHLER A,BREZINA B,QUINTANA L F,et al.Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome:a systematic review[J].Autoimmun Rev,2016,15(1):38-49.
[10] KRONBICHLER A,BREZINA B,GAUCKLER P,et al.Refractory lupus nephritis:When,why and how to treat[J]. Autoimmun Rev,2019,18(5):510-518.
[11] STUMMVOLL G H,SCHMALDIENST S,SMOLEN J S,et al.Lupus nephritis:prolonged immunoadsorption (IAS) reduces proteinuria and stabilizes global disease activity[J]. Nephrol Dial Transplant,2012,27(2):618-626.
[12] LI M X,WANG Y D,QIU Q,et al.Therapeutic effect of double-filtration plasmapheresis combined with methylprednisolone to treat diffuse proliferative lupus nephritis[J]. J Clin Apher,2016,31(4):375-380.
[13] JIANG Y T,TIAN X,GU Y X,et al.Application of plasma exchange in steroid-responsive encephalopathy[J]. Front Immunol,2019,10:324.
[14] YAMADA Y,HARADA M,HARA Y,et al.Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis:a systematic review and meta-analysis[J]. Arthritis Res Ther,2021,23:28.
[15] SZPIRT W M,HEAF J G,PETERSEN J.Plasma exchange for induction and cyclosporine A for maintenance of remission in Wegener's granulomatosis—a clinical randomized controlled trial[J]. Nephrol Dial Transplant,2011,26(1):206-213.
[16] GONG D H,JI D X,XU B,et al.More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy[J]. Ther Apher Dial,2013,17(1):93-98.
[17] SPECKS U,FUSSNER L A,CARTIN-CEBA R,et al.Plasma exchange for the management of ANCA-associated vasculitis:the con position[J]. Nephrol Dial Transplant,2021,36(2):231-236.
[18] WALSH M,MERKEL P A,PEH C A,et al.Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis[J].N Engl J Med,2020,382(7):622-631.
[19] ONUORA S.Plasma exchange fails to improve outcomes for ANCA-associated vasculitis[J]. Nat Rev Rheumatol,2020,16(4):185.
[20] LEMAHIEU W,OMBELET S,LERUT E,et al.Reversal of dialysis-dependent anti-glomerular basement membrane disease using plasma exchange,glucocorticosteroids,and rituximab[J].Kidney Int Rep,2018,3(5):1229-1232.
[21] CUI Z,ZHAO J,JIA X Y,et al.Anti-glomerular basement membrane disease:outcomes of different therapeutic regimens in a large single-center Chinese cohort study[J]. Medicine,2011,90(5):303-311.
[22] BIESENBACH P,KAIN R,DERFLER K,et al.Long-term outcome of anti-glomerular basement membrane antibody disease treated with immunoadsorption[J]. PLoS One,2014,9(7):e103568.
[23] ZHANG Y Y,TANG Z,CHEN D M,et al.Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis[J].BMC Nephrol,2014,15:128.
[24] GULATI K,MCADOO S P.Anti-glomerular basement membrane disease[J].Rheum Dis Clin North Am,2018,44(4):651-673.
[25] PRENDECKI M,PUSEY C.Plasma exchange in anti-glomerular basement membrane disease[J].Presse Med,2019,48(11 Pt 2):328-337.
[26] OSMAN C,JENNINGS R,EL-GHARIANI K,et al.Plasma exchange in neurological disease[J].Pract Neurol,2020,20(2):92-99.
[27] CLARK W F,HUANG S S.Introduction to therapeutic plasma exchange[J].Transfus Apher Sci,2019,58(3):228-229.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	ZHANG Rong, WANG Wen-ting, GU Shun-li, et al. Discussion on Monitoring Process and Blood Transfusion Strategy of Passenger Lymphocyte Syndrome [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 681-685.
[2]	WANG Qian, YANG Li-hui, DING Tian-ling, et al. Clinical Analysis of Platelet Transfusion for Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation with Different Conditioning Regimens [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 686-692.
[3]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 693-695.
[4]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 696-699.
[5]	FU Xiao-yan, ZHANG shuai-hang, SHAO hua, et al. Impact of Erythrocyte Storage Duration on Blood Indexes in Children with Open Heart Surgery by Cardiopulmonary Bypass [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 700-703.
[6]	QIU Li-juan, FU Xiao-yan, GUO Kai, et al. Analysis of Antibody Titers of 60 Pediatric Patients with Strong Positive Platelet Antibody Screening Results [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 704-707.
[7]	WANG Cui-e, LIU Zhi-wei, KONG Chang-hong, et al. Establishment and Application of Clinical Transfusion Service Information Platform [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 715-718.
[8]	JING Yuan-yuan, WANG Jie, LI Dong-mei, et al. Factors Influencing Development of HLA and/or HPA Antibodies in Patients with Platelet Refractoriness [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 723-727.
[9]	MA Ting, NIU Jia-meng, CHEN Xin-yue, et al. Analysis of Blood Transfusion in 8 053 Hospitalized Deceased Patients [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 732-736.
[10]	WANG Rui-han, LIU Hao, LIU Pei, et al. Indication of Intraoperative Cell Salvage in Cesarean Section [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 742-745.
[11]	MA Ling, WU Min-hui, ZHAO Fang, et al. The Genotyping and Alloimmunization Study of RhD among Perinatal Women with RhD Initial Typing Negative [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 746-749.
[12]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 794-796.
[13]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 800-802.
[14]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 803-805.
[15]	. [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2021, 23(6): 806-810.